Allogene Therapeutics Inc (NASDAQ:ALLO)

10.80
Delayed Data
As of Nov 25
 +0.195 / +1.84%
Today’s Change
6.43
Today|||52-Week Range
19.25
-27.65%
Year-to-Date

Today’s Trading

Previous close10.60
Today’s open10.40
Day’s range10.40 - 10.86
Volume40,573
Average volume (3 months)1,657,355
Market cap$1.6B
Data as of 12:59pm ET, 11/25/2022

Growth & Valuation

Earnings growth (last year)+8.98%
Earnings growth (this year)-25.34%
Earnings growth (next 5 years)-31.73%
Revenue growth (last year)--
P/E ratioNM
Price/Sales52.65
Price/Book1.68

Competitors

 Today’s
change
Today’s
% change
DVAXDynavax Technologies...-0.28-2.22%
SAVACassava Sciences Inc+1.26+3.75%
TWSTTwist Bioscience Cor...-0.06-0.24%
----
Data as of 1:00pm ET, 11/25/2022

Financials

Next reporting dateFebruary 23, 2023
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$38.5M
Annual profit (last year)-$257.0M
Net profit margin-667.74%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts